在被诊断患有查检测到的肺癌的成年人中复发的模式
Nikki M Carroll1, Jennifer Eisenstein2, Kris F Wain1
1Institute for Health Research, Kaiser Permanente Colorado, 16601 E Centretech Pkwy, Aurora, CO, USA.
Cancer epidemiology
|February 19, 2025
概括
肺癌查 (LCS) 在早期非小细胞肺癌 (NSCLC) 患者中没有显著改变复发率或生存结果. 所有患者都需要治疗后的监测和幸存者护理,无论检测方法如何.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 癌症查 癌症查
背景情况:
- 肺癌的分期正在转向早期检测.
- 肺癌查计划 (LCS) 越来越多地实施.
- 在社区环境中,LCS对复发和生存的影响仍未得到充分研究.
研究的目的:
- 评估早期非小细胞肺癌 (NSCLC) 的复发率和生存结果.
- 为了比较通过LCS检测到的患者和以其他方式检测到的患者之间的结果.
- 确定影响肺癌复发的因素.
主要方法:
- 在2014-2020年间诊断的916名患者 (I-IIIA阶段NSCLC,55-80岁) 的回顾性分析.
- 基于屏幕检测与非屏幕检测的患者分层.
- 复发率和累积发病率的计算.
- 使用多变量调整的受限制平均生存时间 (aRMST) 评估生存率.
主要成果:
- 23%的患者被检测到; 77%的患者没有被检测到.
- 复发比例相似:22% (未被屏幕检测到) 与17% (被屏幕检测到) (P=0.11).
- 查状态与复发概率没有显著的关联 (RR=0.94).
- 无复发和复发后的生存时间在各组之间是可比的.
结论:
- 早期NSCLC的复发似乎是疾病进展的内在因素,无论检测方法如何.
- 对所有早期NSCLC患者治疗后的监测和幸存者护理至关重要.
- 需要进一步的研究与扩展后续,以证实这些发现.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
